Okairos AG
Okairòs AG is a spin-off company from the IRBM in Rome (Merck Inc.) focusing on the discovery and development of genetic T-cell vaccines including hepatitis C virus (HCV).
Okairòs AG is a spin-off company from the IRBM in Rome (Merck Inc.) focusing on the discovery and development of genetic T-cell vaccines including hepatitis C virus (HCV).